Tag: postmarket surveillance

How the FDA Monitors Drug Safety After Medication Approval

By Joe Barnett    On 2 Feb, 2026    Comments (10)

blog-post-image

The FDA doesn't stop monitoring drugs after approval. Using FAERS, Sentinel, AI tools, and REMS programs, it tracks side effects in millions of real-world patients to catch hidden risks and protect public health.

View More

Categories

Recent Post

recent-post-image Why Prices Drop at Launch: The Real Reason First Generic Entries Crush Costs
recent-post-image Direct-to-Consumer Generic Pharmacies: How New Business Models Are Changing How You Get Medications
recent-post-image Estriol and Breast Cancer Risk: What the Latest Research Shows
recent-post-image Adverse Event Monitoring for Biosimilars: How Safety Surveillance Keeps Patients Protected
recent-post-image Why Regular Check-ups Are Critical for Discoid and Systemic Lupus Patients

Menu

© 2026. All rights reserved.